| Health Care Technology Industry | Healthcare Sector | Dr. Zhong Zhao Ph.D. CEO | XFRA Exchange | CNE100004JD2 ISIN |
| DE Country | 875 Employees | 27 May 2026 Last Dividend | - Last Split | - IPO Date |
Zylox-Tonbridge Medical Technology Co., Ltd., established in 2012 and headquartered in Hangzhou, People's Republic of China, operates as a pioneering medical device company on both domestic and international fronts. The genesis of the company was under the name Zhejiang Zylox Medical Device Co., Ltd., which was later revised to its current designation in March 2021. Zylox-Tonbridge is dedicated to advancing the field of neuro- and peripheral-vascular interventional medical devices, leveraging its deep technical expertise to serve patients and physicians across the globe. In addition to producing cutting-edge medical devices, the company extends technical consultation and services, strengthening its position as a comprehensive provider in the healthcare sector. Furthermore, it engages in the importation of materials essential for its innovative product development processes.
Zylox-Tonbridge Medical Technology Co., Ltd. offers an expansive range of products and services tailored to meet the demanding needs of the neurovascular and peripheral-vascular interventional medicine sectors: